Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma

Documenti analoghi

• Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents
  di: Hideko Ohama, et al.
  Pubblicazione: (2024)
• Progression pattern and post‐progression survival following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma
  di: Satoshi Kobayashi, et al.
  Pubblicazione: (2024)
• Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients
  di: Takeshi Hatanaka, et al.
  Pubblicazione: (2024)
• Adjusting to living with chronic liver disease among patients who continue regular healthcare visits for hepatocellular carcinoma surveillance: A grounded theory study
  di: Keiko Hatanaka, et al.
  Pubblicazione: (2024)
• Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response
  di: Jung Eun Park, et al.
  Pubblicazione: (2024)